GlassScriptPhysician profile
Areej Khan
NPI 1821495326
$1,112.54
in general payments reported to CMS, 2019-2025
17 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.59 · 2021: $92.35 · 2022: $156 · 2023: $282 · 2024: $382 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $265.93 | 2021-2024 | |
| Insmed, INC. | $203.63 | 2022-2024 | Arikayce |
| Merck Sharp & Dohme LLC | $104.58 | 2024-2025 | Zerbaxa, Dificid, Pifeltro |
| Viiv Healthcare Company | $99.05 | 2022-2025 | Dovato, Cabenuva |
| Aimmune Therapeutics, INC. | $65.33 | 2025 | Vowst |
| Shionogi INC | $60.28 | 2021-2024 | Fetroja |
| Ferring Pharmaceuticals INC. | $57.98 | 2023-2024 | Rebyota |
| Exact Sciences Corporation | $57.18 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Abbvie INC. | $33.02 | 2022 | |
| Janssen Pharmaceuticals, INC | $31.59 | 2019 | |
| Pfizer INC. | $25.52 | 2022 | |
| Lundbeck LLC | $20.97 | 2021 | |
| Paratek Pharmaceuticals, INC. | $20.11 | 2025 | Nuzyra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.58 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.04 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.60 | 2021 | |
| Phathom Pharmaceuticals, INC. | $14.15 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Areej Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.